A glimpse of the genetics of young‐onset Parkinson’s disease in Central Asia

• Main Authors: Rauan Kaiyrzhanov, Akbota Aitkulova, Jana Vandrovcova, David Murphy, Nazira Zharkinbekova, Chingiz Shashkin, Vadim Akhmetzhanov, Gulnaz Kaishibayeva, Altynay Karimova, Zhanybek Myrzayev, Malgorzata Murray, Talgat Khaibullin, John Hardy, Henry Houlden
• Format: Article
• Language: English
• Published: Wiley 2021-06-01
• Series: Molecular Genetics & Genomic Medicine
• Subjects: age of onset; Central Asia; genetics; Kazakhstan; LRRK2; Parkinson's disease
• Online Access: https://doi.org/10.1002/mgg3.1671

ABSTRACT Background Knowledge of the genetic background of many human diseases is currently lacking from genetically undiscovered regions, including Central Asia. Kazakhstan is the first Central Asian country where the genetic studies of Parkinson's disease (PD) have been emerging since it had become a member of the International Parkinson Disease Genomics Consortium. Here we report on the results of whole‐exome sequencing (WES) in 50 young‐onset PD (YOPD) cases from Kazakhstan. Methodology WES was performed on 50 unrelated individuals with YOPD from Kazakhstan. Exome data were screened for novel/ultra‐rare deleterious variants in known and candidate PD genes. Copy number variants and small indels were also called. Results Only three cases (6%) were found to be positive for known PD genes including two unrelated familial PD cases with LRRK2 p.(Arg1441Cys) and one case with a homozygous pathogenic PRKN p.(Arg84Trp) variant. Four cases had novel and ultra‐rare variants of uncertain significance in LRRK2, DNAJC13, and VPS35. Novel deleterious variants were found in candidate Mendelian PD genes including CSMD1, TNR, EIF4G1, and ATP13A3. Eight cases harbored the East Asian‐specific LRRK2 p.(Ala419Val) variant. Conclusions The low diagnostic yield in our study might imply that a significant proportion of YOPD cases in Central Asia remains unresolved. Therefore, a better understanding of the genetic architecture of PD among populations of Central Asian ancestry and the pathogenicity of numerous rare variants should be further investigated. WES is a valuable technique for large‐scale YOPD genetic studies in Central Asia.